XML 22 R8.htm IDEA: XBRL DOCUMENT v2.3.0.15
Equity
9 Months Ended
Sep. 30, 2011
Equity 
Equity

Note 4— Equity

 

Equity-based Compensation

 

Equity-based compensation cost is measured at the grant date, based on the fair value of the award, and is recognized as expense over each employee’s requisite service period. The following compensation expense was included in the Condensed Consolidated Statements of Income for the three and nine months ended September 30, 2011 and 2010 (in thousands):

 

 

 

Three months ended

 

Nine months ended

 

 

 

September 30,

 

September 30,

 

 

 

2011

 

2010

 

2011

 

2010

 

Equity-based compensation expense

 

$

2,951

 

$

2,356

 

$

9,472

 

$

6,222

 

 

As a result of the discontinuance of our CIGS solar systems business, equity-based compensation expense related to Solar employees totaling $0.1 million and $0.7 million, and $0.3 million and $0.8 million has been classified as discontinued operations in determining the Condensed Consolidated Statements of Income for the three and nine months ended September 30, 2011 and 2010, respectively.

 

As a result of the sale of our Metrology segment to Bruker, equity-based compensation expense related to Metrology employees totaling $4.9 million and $5.6 million has been classified as discontinued operations in determining the Condensed Consolidated Statements of Income for the three and nine months ended September 30, 2010, respectively.

 

As of September 30, 2011, the total unrecognized compensation costs related to nonvested stock and stock option awards was $17.0 million and $14.8 million, respectively. The related weighted average period over which we expect that such unrecognized compensation costs will be recognized is approximately 3.2 years for nonvested stock awards and 2.0 years for option awards.

 

Stock Option and Restricted Stock Activity

 

A summary of our restricted stock awards including restricted stock units for the nine months ended September 30, 2011, is presented below:

 

 

 

Shares
(000’s)

 

Weighted-
Average
Grant-Date
Fair Value

 

Nonvested at December 31, 2010

 

616

 

$

19.06

 

Granted

 

279

 

51.11

 

Vested

 

(173

)

14.33

 

Forfeited (including cancelled awards)

 

(87

)

26.83

 

Nonvested at September 30, 2011

 

635

 

$

33.36

 

 

A summary of our stock option awards for the nine months ended September 30, 2011, is presented below:

 

 

 

Shares (000s)

 

Weighted-
Average
Exercise
Price

 

Aggregate
Intrinsic
Value (000s)

 

Weighted-
Average
Remaining
Contractual Life
(in years)

 

Outstanding at December 31, 2010

 

2,569

 

$

19.71

 

 

 

 

 

Granted

 

368

 

50.65

 

 

 

 

 

Exercised

 

(638

)

15.63

 

 

 

 

 

Forfeited (including cancelled options)

 

(141

)

29.17

 

 

 

 

 

Outstanding at September 30, 2011

 

2,158

 

$

25.56

 

$

19,273

 

6.1

 

Options exercisable at September 30, 2011

 

1,006

 

$

17.92

 

$

12,482

 

4.6

 

 

Treasury Stock

 

On August 24, 2010, our Board of Directors authorized the repurchase of up to $200 million of our common stock. This repurchase program was completed by August 19, 2011. Repurchases were made from time to time on the open market in accordance with applicable federal securities laws. During the three months ended September 30, 2011, we purchased 3,994,940 shares for $154.3 million (including transaction costs) under the program at an average cost of $38.63 per share. During the nine months ended September 30, 2011, we purchased 4,160,228 shares for $162.1 million (including transaction costs) under the program at an average cost of $38.96 per share. These stock repurchases are included as a reduction to Equity in the Condensed Consolidated Balance Sheet.